In many cases, starting a GLP-1 means a patient can safely reduce or completely eliminate one or two of their old blood pressure medications
Long-Term Sustainability: Recent long-term analyses of the SURMOUNT-1 study, presented at the European Congress on Obesity (ECO) in May 2025, indicate that Tirzepatide can produce clinically meaningful and sustained weight reduction for at least 3 years
Podiatrists have noted this can include a loss of soft tissue, noting a reduction in fat padding can affect the cushioning of the heels and balls of the feet, resulting in foot pain
GLP-1 receptor agonists (GLP-1s) have recently become high-profile drugs for type 2 diabetes (T2D) and especially for obesity/weight loss
Contact Klinic in Illinois to arrange your consultation, as we facilitate coast-to-coast services to ensure access to all necessary tools for successful medical weight loss
This process can promote lean muscle growth and support overall liver health